Genome Analysis Articles & Analysis

SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in Middle Eastern markets. Under the terms of this agreement, Global Diagnostic Solutions Ltd. will be responsible for the Business Development, ...

By SeqOne S.A.S.

SeqOne Genomics, provider of next-generation genomic analysis solutions for personalized medicine is proud to announce a new strategic partnership with ILC Instrumentos de Laboratório Científicos to facilitate access to its genomic analysis solutions in Portugal. Through this partnership, ILC Instrumentos de Laboratório Científicos has been appointed as a value added ...

By SeqOne S.A.S.

inDNA Research Labs is an early stage genomics-driven personalized healthcare startup that is at the forefront of trying to bring comprehensive genomic analysis to routine clinical care. Our goal is to democratize the use of genomics technologies by empowering physicians to utilize a patient’s genomic profile to improve clinical decisions thus transforming patient care. This website is ...

By inDNA Research Labs

The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in ...

By SeqOne S.A.S.

The project aims to compare the clinical utility of broad-spectrum genomic profiling in the treatment of late-stage cancer patients with more traditional approaches that analyze a limited set of genes and thus influence the precision medicine strategy of the French national health system SeqOne Genomics, developer of next generation genomic analysis solutions, announced that it has been selected ...

By SeqOne S.A.S.

SeqOne Genomics, a start-up specialized in genomic analysis software, is partnering with leading medical testing labs to develop an approach that delivers up to 100 times more COVID 19 tests per machine thanks to NGS sequencers. Epidemiological experts agree that the key to successfully managing the COVID 19 pandemic is a robust national testing capability that can dispense hundreds of thousands ...

By SeqOne S.A.S.

SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology. i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking start-ups. The award is associated with a grant aimed at helping each ...

By SeqOne S.A.S.

Genome analysis of 234 bulls has put researchers, including several from Wageningen Livestock Research, on the trail of DNA variants which influence particular characteristics in breeding bulls. For example, two variants have proven responsible for disruptions to the development of embryos and for curly hair, which is disadvantageous because more ticks and parasites occur in curly hair than in ...

By Wageningen University and Research Centre

Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced the launch of an integrated genomic scar analysis for homologous recombination deficiency (HRD) in the version 6.2 software release of NxClinical. ...

By BioDiscovery, A Bionano Genomics Company

Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. The platform is a leading open solution for data-driven innovation, which aims to discover hidden potential in biological data and unearth ...

By CD Genomics

Company’s latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification” EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 18th Annual PEGS Boston Conference, a protein engineering and cell therapy ...

By Bruker Corporation

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics recently launched various types of genotyping analysis services, including analysis of data generated by different ...

By CD Genomics

CD Genomics, a renowned provider of genomics and bioinformatics services, is spearheading a new era of genomic research with its cutting-edge Transcriptomic Data Analysis service. This innovative service is poised to revolutionize the exploration of gene expression and regulation, offering researchers unparalleled insights into the intricate world of the transcriptome. At the heart of CD ...

By CD Genomics

Durham, N.C., Nov. 8, 2021 – GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the closing of an oversubscribed Series B1 financing, which raised $7.5 million. Proceeds will be used to commercialize GeneCentric’s gene signatures and accelerate the growth of its pipeline of predictive response signatures for ...

By GeneCentric Therapeutics, Inc.

MicrobioSeq is the microbial genomics division on behalf of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a renowned reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. The product manager is pleased to announce the launch of the Plasmid Identification service, thus helping researchers to efficiently ...

By CD Genomics

Based on rich experience in genomic analysis, CD Genomics has developed a specialized platform for targeted sequencing of cancer-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. The company has optimized its Cancer Hotspot Panel Sequencing service to meet the most challenging research process. Cancer is ...

By CD Genomics

CD Genomics is one of the top genomics service providers in genomic research, devoting to providing reliable services to pharmaceutical and biotech companies as well as academia and government agencies. With its next-generation sequencing and third-generation sequencing platforms, CD Genomics can provide a wide range of services, such as genome sequencing, RNA sequencing, and epigenomics ...

By CD Genomics

Intus Bios, a microbiome research company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into an exclusive distribution partnership with BioCat GmbH, a leading provider of life sciences solutions, for the promotion, sale and support of all Intus Biosciences products and software in Germany, Austria, and Switzerland. Founded in ...

By Intus Biosciences, LLC

The Bioinformatics-Analysis is a subdivision of CD Genomics, providing reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction services, and other related data analysis services. The company is pleased to announce the launch of the CRISPR off-target analysis service to help researchers optimize the CRISPR ...

By CD Genomics

Collection of fresh-frozen tumor samples is often challenging or infeasible, leading many studies to rely on formalin-fixed, paraffin-embedded (FFPE) tumor tissue samples. Because these tissues are often paired with a great deal of clinical and outcome data, analysis of these archives has the potential to lead to major advances in cancer treatment and prevention. Whole-genome sequencing (WGS) ...

By Genuity Science